NCT00661479 - An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

May 31, 2010

Conditions

Retinitis Pigmentosa

Interventions

DRUG

400 µg Brimonidine Tartrate Implant

400 µg brimonidine tartrate implant in the study eye on Day 1.

DRUG

200 µg Brimonidine Tartrate Implant

200 µg brimonidine tartrate implant in the study eye on Day 1.

DRUG

100 µg Brimonidine Tartrate Implant

100 µg brimonidine tartrate implant in the study eye on Day 1.

OTHER

Sham (no implant)

Sham in the fellow eye on Day 1.

Trial Locations (4)

Arlington

Paris

Tübingen

Coimbra